Promising new agents in the treatment of non-small cell lung cancer Martin J. EdelmanDavid R. Gandara Original Article Pages: 385 - 393
Determination of extracellular methotrexate tissue levels by microdialysis in a rat model Per O. EkstrømAnders AndersenLars Slørdal Original Article Pages: 394 - 400
Formulation and stability of busulfan for intravenous administration in high-dose chemotherapy Harshal P. BhagwatwarSasima PhadungpojnaBorje S. Andersson Original Article Pages: 401 - 408
Clinical and experimental pharmacokinetic interaction between 6-mercaptopurine and methotrexate Federico InnocentiRomano DanesiMario Del Tacca Original Article Pages: 409 - 414
High-dose 7-hydroxymethotrexate: Acute toxicity and lethality in a rat model Eivind SmelandOle Martin FuskevågJarle Aarbakke Original Article Pages: 415 - 422
Cell-cycle arrests and p53 accumulation induced by geldanamycin in human ovarian tumour cells A. J. McIlwrathV. G. BruntonR. Brown Original Article Pages: 423 - 428
A single-sample assay for the estimation of the area under the free carboplatin plasma concentration versus time curve Saad Ghazal-AswadA. Hilary CalvertDavid R. Newell Original Article Pages: 429 - 434
In vivo antitumor activity of cis-bis-neodecanoato-trans- R,R-l,2-diaminocyclohexane platinum(II) formulated in long-circulating liposomes Atsuhide MoriSu-Ping WuLeaf Huang Original Article Pages: 435 - 444
Natural killer cell activity in chronic lymphocytic leukemia patients treated with fludarabine L. E. RobertsonA. W. DennyJ. A. Nelson Original Article Pages: 445 - 450
Stereoselective pharmacokinetics of ifosfamide and its 2- and 3-N-dechloroethylated metabolites in female cancer patients Camille P. GranvilJulie DucharmeIrving W. Wainer Original Article Pages: 451 - 456
Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells Hemant ParekhHenry Simpkins Original Article Pages: 457 - 462
cis-Diamminedichloroplatinum(II)-induced cell death through apoptosis in sensitive and resistant human ovarian carcinoma cell lines Michael G. OrmerodCiaran O’NeillKenneth R. Harrap Original Article Pages: 463 - 471
Pharmacology of N,N-di(n-butyl)adriamycin-14-valerate in the rat Guozhu HanMervyn IsraelTrevor W. Sweatman Original Article Pages: 472 - 478
The effect of treatment with high dose melphalan, cisplatin or carboplatin on levels of glutathione in plasma, erythrocytes, mononuclear cells and urine Linda HogarthMartin EnglishAndrew G. Hall Original Article Pages: 479 - 485
Dependence of fluorodeoxyuridine-induced cytotoxicity and megabase DNA fragment formation on S phase progression in HT29 cells Hsin-yi Y. TangKris L. WeberJonathan Maybaum Original Article Pages: 486 - 490
Gemcitabine: A phase II study in patients with advanced renal cancer P. H. M. De MulderL. WeissbachJ. Blatter Clinical Trial Report Pages: 491 - 495
Phase II study of mitomycin, ifosfamide and cisplatin in adenocarcinoma of the oesophagus Simon M. AllenJohn P. DuffyHugoe R. Matthews Clinical Trial Report Pages: 496 - 498
Plasma alcohol concentrations in patients following paclitaxel infusion Lorraine K. WebsterNicholas A. CrinisMichael J. Millward Short communication Pages: 499 - 501
Effects of granisetron with doxorubicin or epirubicin on ECG intervals Ismo T. JantunenVesa V. KatajaTapani Parviainen Short Communication Pages: 502 - 504